about
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in ratsVancomycin- and erythromycin-induced hearing loss in humansMycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.Anaphylaxis avoidance and management: educating patients and their caregivers.Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized studyAnaphylaxis during the perioperative period.Application of a Bayesian method to monitor and adjust vancomycin dosage regimensComparative antibacterial activity of Vancocin and generic vancomycin.Effect of orally administered activated charcoal on vancomycin clearanceRandomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients.Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.Sensitive radioimmunoassay for vancomycin.Comparison of vancomycin disposition in rats with normal and abnormal renal functions.Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations.Effects of hepatic function on vancomycin clinical pharmacology.Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.Antibiotics for streptococcal endocarditisRosaramicin versus penicillin G in experimental Pneumococcal meningitis.Methicillin-resistant staphylococci.Antimicrobial therapy for the elderly patient.Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis.Vancomycin ototoxicity in patients with normal renal function.Gentamicin-resistant enterococci and endocarditis.Vancomycin: an update.Determination of vancomycin in human serum by high-pressure liquid chromatography.Effects of vancomycin on renal function in rats.Aging and infective endocarditis.Gastrointestinal instrumentation, bacteraemia, and endocarditis.Comparison of fluorescence polarization immunoassay and bioassay of vancomycin.Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.Ototoxicity of oral neomycin and vancomycin.Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.Safety of oral vancomycin in functionally anephric patientsInteractions between antibiotics and human neutrophils in the killing of staphylococci.Independent organic cation transport activity of Na(+)-L-carnitine cotransport system in LLC-PK(1) cells.Evaluation of an automated fluorescence polarization immunoassay for vancomycin.Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability.
P2860
Q24671879-086D57F3-C143-482E-85D8-E29EBBCE3AB7Q28374187-0F70D0A0-9FAA-498D-8A5A-7A975742B6E9Q30502734-1FFABD66-8C62-4B00-B81B-FFF9A4FD29C4Q33741753-22AB4629-273D-4F99-B9DE-30D238E4E817Q33895403-77EA621F-3D86-44A1-885E-C9E253358D0CQ33982863-BFF4B67D-CF84-4D80-AE3F-316761F55DF8Q34236662-50A150F6-DB5E-4D4B-A921-59FE91582157Q35261758-6B8D83BE-E610-46CB-9937-C204013BCECFQ35537147-860DB03A-6A24-442D-B2CB-ECE5AA2C549AQ35539894-D1F41016-D051-43F5-9E69-0B93E1D3ABADQ35574149-ABD5C7F4-7097-4A38-BDF0-A3888380A1A7Q35648058-45214C4D-2782-4AA8-81F7-21835665C38CQ35668501-B813B0BA-1503-4A51-9414-101C8ECA2A0EQ35672503-FB1E73F6-8805-4A8D-92CE-20A84FC1F2B2Q35716241-45F28480-6169-4F82-912D-96EA476FDDA9Q35740505-A19D048E-42CD-44E0-AE5C-008FDEF4357CQ35758671-42C5D0DF-97C7-4603-A877-3A3758CA398FQ35809992-5BAF58D3-1BB6-477F-9CFE-6C2A56B52384Q36462495-C057EBBE-DCC9-4216-9830-A06B5F7DA634Q36486561-52FE5B39-8968-4376-A646-680116ADE002Q36632851-D68FD8D0-1193-442E-B227-4371DB3CB1E7Q38006505-0AA2E8C6-3FE1-40EA-A4A4-5E928CC92A34Q38503990-2F072027-CA78-44D4-90A7-A2F8F7C03037Q38582952-02BE81C5-25BA-4D08-BDE4-93C5F43915A5Q39199275-C6FF2289-A538-4329-9484-4FC87445AF47Q39746652-DBD86301-1936-4C79-8809-96717D3F6C85Q39849614-C8A47B2F-AB5E-4781-9F77-715774943099Q39854572-0157DF3A-E2CF-4371-8F9D-7C7E8449130AQ40146510-CC2BC665-9252-408E-8B64-E1039F6441A5Q40160347-CDD5BFE0-07CB-4FC2-909A-99CD92DF1632Q40218850-7B7DC3F4-ADD0-4EF7-8793-81A5FB1D340BQ40219056-2AEF03C1-7FFA-4C0D-9808-7E0162D7F3FEQ40270547-4E3D874E-409B-4F5B-A137-2646F9376D22Q40281878-000EBC4F-CDE5-4235-A03A-E6B84947CD8BQ40281952-F0976901-17C1-4C11-AAAF-06F77F5A23E9Q40619365-5F9E36C1-6E5D-4A08-BEE6-79A9619F2283Q40687700-F39F9926-3909-4DAF-86F5-857BA919D409Q40791979-46269D99-D44A-4FAB-9AF1-CE040C49EC36Q41939413-61692131-017D-46BD-9AB7-A641A297D6FAQ42012983-0072996A-457D-48AC-B85E-6A05F348BCF8
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Vancomycin revisited.
@en
Vancomycin revisited.
@nl
type
label
Vancomycin revisited.
@en
Vancomycin revisited.
@nl
prefLabel
Vancomycin revisited.
@en
Vancomycin revisited.
@nl
P1476
Vancomycin revisited.
@en
P2093
P304
P356
10.7326/0003-4819-88-6-813
P407
P577
1978-06-01T00:00:00Z